# Sublimity Therapeutics Holdco

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sublimity-therapeutics-holdco

- Industry: Pharmaceuticals
- Headquarters: Dublin, Ireland
- Website: www.sublimitytherapeutics.com
- Total disclosed funding: $2.5M
- Latest round: Series B (Aug 17, 2020)
- Investors on record: 1

## About

Sublimity Therapeutics Holdco Limited is a biopharmaceutical company focused on developing innovative therapies designed to treat autoimmune diseases using unique delivery systems for biologics.Founded in 2000 and headquartered in Dublin, Ireland, Sublimity Therapeutics Holdco Limited specializes in creating advanced treatments for autoimmune conditions. In August 2020, the company successfully raised EUR 1.09 mn in Series B funding from HBM Partners, marking the latest in a series of three funding deals overall. The founder's background is not specified, nor are there mentions of prior companies.Sublimity Therapeutics develops targeted therapies for autoimmune diseases, particularly focusing on biologic treatments. Their offerings are designed to enhance patient adherence and effectiveness of therapy, serving various healthcare markets. The company's products are strategically positioned in Europe and North America, allowing for widespread distribution and support.In the 2019 financial year, Sublimity Therapeutics reported a revenue of EUR 0 and an EBITDA loss of EUR -18,121,554.90. The company's revenue model revolves around B2B partnerships and direct sales, emphasizing tailored engagements with clients.Sublimity Therapeutics is focused on expanding its product portfolio with plans to launch new therapies aimed at specific autoimmune disorders in the next two years. The company aims to penetrate additional markets in North America and Asia by 2023. The recent funding of EUR 1.09 mn raised in August 2020 will support these strategic initiatives, enhancing research and development efforts.

## Funding rounds

- Series B, Aug 17, 2020, $1.3M — HBM Partners
- Series B, Jan 31, 2020, $1.3M — HBM Partners

## Investors

- HBM Partners (https://capitalatlas.ai/funds/hbm-partners) — Series B